These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38428413)

  • 21. IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling.
    Hu WT; Li MQ; Liu W; Jin LP; Li DJ; Zhu XY
    Mol Hum Reprod; 2014 Apr; 20(4):358-72. PubMed ID: 24344240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction.
    Lu W; Xie Z; Tang Y; Bai L; Yao Y; Fu C; Ma G
    Theranostics; 2015; 5(10):1068-82. PubMed ID: 26199646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo.
    Collington SJ; Hallgren J; Pease JE; Jones TG; Rollins BJ; Westwick J; Austen KF; Williams TJ; Gurish MF; Weller CL
    J Immunol; 2010 Jun; 184(11):6114-23. PubMed ID: 20427772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of gene transcripts for cell signaling receptors in bone marrow-derived hematopoietic stem/progenitor cell and mesenchymal stromal cell populations.
    Anam K; Davis TA
    Stem Cell Res Ther; 2013 Sep; 4(5):112. PubMed ID: 24405801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro.
    Xu F; Shi J; Yu B; Ni W; Wu X; Gu Z
    Oncol Rep; 2010 Jun; 23(6):1561-7. PubMed ID: 20428810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted homing of CCR2-overexpressing mesenchymal stromal cells to ischemic brain enhances post-stroke recovery partially through PRDX4-mediated blood-brain barrier preservation.
    Huang Y; Wang J; Cai J; Qiu Y; Zheng H; Lai X; Sui X; Wang Y; Lu Q; Zhang Y; Yuan M; Gong J; Cai W; Liu X; Shan Y; Deng Z; Shi Y; Shu Y; Zhang L; Qiu W; Peng L; Ren J; Lu Z; Xiang AP
    Theranostics; 2018; 8(21):5929-5944. PubMed ID: 30613272
    [No Abstract]   [Full Text] [Related]  

  • 27. CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation.
    Yao M; Fang W; Smart C; Hu Q; Huang S; Alvarez N; Fields P; Cheng N
    Mol Cancer Res; 2019 Feb; 17(2):604-617. PubMed ID: 30446625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The enhancement of CCL2 and CCL5 by human bone marrow-derived mesenchymal stem/stromal cells might contribute to inflammatory suppression and axonal extension after spinal cord injury.
    Yagura K; Ohtaki H; Tsumuraya T; Sato A; Miyamoto K; Kawada N; Suzuki K; Nakamura M; Kanzaki K; Dohi K; Izumizaki M; Hiraizumi Y; Honda K
    PLoS One; 2020; 15(3):e0230080. PubMed ID: 32155215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells.
    Macanas-Pirard P; Quezada T; Navarrete L; Broekhuizen R; Leisewitz A; Nervi B; Ramírez PA
    PLoS One; 2017; 12(1):e0168888. PubMed ID: 28045930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extramedullary myelopoiesis in malaria depends on mobilization of myeloid-restricted progenitors by IFN-γ induced chemokines.
    Belyaev NN; Biró J; Langhorne J; Potocnik AJ
    PLoS Pathog; 2013; 9(6):e1003406. PubMed ID: 23762028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells.
    Molloy AP; Martin FT; Dwyer RM; Griffin TP; Murphy M; Barry FP; O'Brien T; Kerin MJ
    Int J Cancer; 2009 Jan; 124(2):326-32. PubMed ID: 19003962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chrono-pharmacological Targeting of the CCL2-CCR2 Axis Ameliorates Atherosclerosis.
    Winter C; Silvestre-Roig C; Ortega-Gomez A; Lemnitzer P; Poelman H; Schumski A; Winter J; Drechsler M; de Jong R; Immler R; Sperandio M; Hristov M; Zeller T; Nicolaes GAF; Weber C; Viola JR; Hidalgo A; Scheiermann C; Soehnlein O
    Cell Metab; 2018 Jul; 28(1):175-182.e5. PubMed ID: 29861387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.
    Martinu T; Gowdy KM; Nugent JL; Sun J; Kinnier CV; Nelson ME; Lyes MA; Kelly FL; Foster WM; Gunn MD; Palmer SM
    Am J Respir Cell Mol Biol; 2014 Dec; 51(6):810-21. PubMed ID: 24921973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCL2 expression.
    Che N; Li X; Zhang L; Liu R; Chen H; Gao X; Shi S; Chen W; Sun L
    J Immunol; 2014 Nov; 193(10):5306-14. PubMed ID: 25339674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain.
    Andres RH; Choi R; Pendharkar AV; Gaeta X; Wang N; Nathan JK; Chua JY; Lee SW; Palmer TD; Steinberg GK; Guzman R
    Stroke; 2011 Oct; 42(10):2923-31. PubMed ID: 21836091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCL2-CCR2 signaling promotes hepatic ischemia/reperfusion injury.
    Zhang J; Xu P; Song P; Wang H; Zhang Y; Hu Q; Wang G; Zhang S; Yu Q; Billiar TR; Wang C; Zhang J
    J Surg Res; 2016 May; 202(2):352-62. PubMed ID: 27229110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: identification of CCL2/CCR2-dependent gene expression profile.
    Sierra-Filardi E; Nieto C; Domínguez-Soto A; Barroso R; Sánchez-Mateos P; Puig-Kroger A; López-Bravo M; Joven J; Ardavín C; Rodríguez-Fernández JL; Sánchez-Torres C; Mellado M; Corbí AL
    J Immunol; 2014 Apr; 192(8):3858-67. PubMed ID: 24639350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCL2/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms.
    Fang WB; Jokar I; Zou A; Lambert D; Dendukuri P; Cheng N
    J Biol Chem; 2012 Oct; 287(43):36593-608. PubMed ID: 22927430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model.
    Teng KY; Han J; Zhang X; Hsu SH; He S; Wani NA; Barajas JM; Snyder LA; Frankel WL; Caligiuri MA; Jacob ST; Yu J; Ghoshal K
    Mol Cancer Ther; 2017 Feb; 16(2):312-322. PubMed ID: 27980102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.